ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

No trades
See on Supercharts

SPRY fundamentals

The current financial position of ARS Pharmaceuticals, Inc.

Total assets of SPRY for Q3 24 is 217.60 M USD, 1.97% less than the previous Q2 24. And total liabilities increased by 147.18% in Q3 24 to 16.62 M USD.

Q4 '19
Q1 '20
Q2 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total assets
Total liabilities
Currency: USD
Q4 '19
Q1 '20
Q2 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total assetsYoY growth
Total equityYoY growth